Abiopharma

News list

Director Du Hong 🟡 adjusted position in 3.1K shares (1 derivative) of WEIBO Corp (WB) at $7.67 Transaction Date: Aug 16, 2026 | Filing ID: 098097

Full text

News bot Aug. 18, 2026, 10:41 a.m.
🔍 Du Hong (Director)

Company: WEIBO Corp (WB)

Report Date: 2026-08-16
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 6,250
- Total shares sold: 9,355
Detailed Transactions and Holdings:
- Acquired 6,250 shares of ADS (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 110,975.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 3,105 shares of ADS at $7.6661 per share (Direct)
  Date: 2026-08-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 107,870.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 6,250 shares of Restricted Share (Derivative)
  Date: 2026-08-16 | Code: C | Exercise: 2026-08-16 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Acquired from vested restricted shares. Each American depositary share represents one Class A ordinary share.
- F2: Represents ADSs sold pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted share.
- F3: The restricted shares do not have an expiration date.